ANTARES PHARMA, INC. reports

Company location: Ewing, NJ
Fiscal year end: 31 December

ANTARES PHARMA, INC. has filed 1,187 SEC EDGAR filings since 24 Jun 1996

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 251-275 of 688 matching filings.

Per page

25

Current page

11

4

FORM 4 SUBMISSION

Filing date: 13 Jun 2018
Reporting date: 11 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Jun 2018
Reporting date: 08 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Jun 2018
Reporting date: 08 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Jun 2018
Reporting date: 08 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Jun 2018
Reporting date: 08 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Jun 2018
Reporting date: 08 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Jun 2018
Reporting date: 08 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Jun 2018
Reporting date: 07 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Jun 2018
Reporting date: 07 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Jun 2018
Reporting date: 07 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Jun 2018
Reporting date: 05 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jun 2018
Reporting date: 01 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jun 2018
Reporting date: 02 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jun 2018
Reporting date: 02 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-32302

8-K INVESTOR PRESENTATION

Filing date: 05 Jun 2018
Reporting date: 05 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 01 Jun 2018
Reporting date: 30 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 May 2018
Reporting date: 28 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 24 May 2018
Reporting date: 22 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 22 May 2018
Reporting date: 18 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 18 May 2018
Reporting date: 16 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 May 2018
Reporting date: 14 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 May 2018
Reporting date: 11 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 May 2018
Reporting date: 10 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 May 2018
Reporting date: 09 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-32302

8-K INVESTOR PRESENTATION

Filing date: 09 May 2018
Reporting date: 09 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .